On 21 May 2024, the European Medicines Agency (“EMA”) published a revised version of the Questions & Answers for applicants, Marketing Authorisation Holders of medicinal products and notified bodies ...
The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of approximately 9% during the forecast period. This growth is largely driven by the ...
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Drug Device Combination Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...
Drug–device combination products are becoming increasingly prevalent, with many lasting years beyond the expiration date of primary and secondary patents on the drug itself. It is unknown how common ...
"By definition, all antimicrobial-coated devices are combination products," explains Marc Mittelman, senior managing scientist, occupational and environmental health, Exponent (Menlo Park, CA). "Thus, ...
While the concept of a combination product is not new, these unique healthcare products (drug plus device, biological plus device, drug plus biological product, or drug plus device plus biological ...
"Discover the dynamic intersection of pharmaceuticals and medical devices, where innovative drug-device combinations are revolutionizing healthcare. BCC Research Study Projects 9.1% CAGR, with Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback